Intra-aortic balloon pump: current evidence & future perspectives

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Kantrowitz J. The intra-aortic balloon pump: an early chapter in translational medicine. Artif. Organs 39(6), 457–472 (2015).
  MedlineGoogle Scholar
• 2 O'gara PT, Kushner FG, Ascheim DD et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Circulation 127(4), e362 (2013).
  MedlineGoogle Scholar
• 3 Amsterdam EA, Wenger NK, Brindis RG et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. Circulation 130(25), e344 (2014).
  MedlineGoogle Scholar
• 4 Antman EM, Anbe DT, Armstrong PW et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction – executive summary. Circulation 110(5), 588 (2004).
  MedlineGoogle Scholar
• 5 Perera D, Stables R, Clayton T et al. Long-term mortality data from the Balloon Pump-Assisted Coronary Intervention Study (BCIS-1). Circulation 127(2), 207 (2013). • Randomized-controlled study with over 300 patients for intra-aortic balloon pump (IABP) in the context of percutaneous coronary intervention.
  MedlineGoogle Scholar
• 6 Fasseas P, Cohen M, Kopistansky C et al. Pre-operative intra-aortic balloon counterpulsation in stable patients with left main coronary disease. J. Invasive Cardiol. 13(10), 679–683 (2001).
  Medline CASGoogle Scholar
• 7 Holman WL, Li Q, Kiefe CI et al. Prophylactic value of preincision intra-aortic balloon pump: analysis of a statewide experience. J. Thorac. Cardiovasc. Surg. 120(6), 1112–1119 (2000).
  Medline CASGoogle Scholar
• 8 Cochran RP, Starkey TD, Panos AL, Kunzelman KS. Ambulatory intraaortic balloon pump use as bridge to heart transplant. Ann. Thorac. Surg. 74(3), 746–751 (2002).
  MedlineGoogle Scholar
• 9 Patel MR, Smalling RW, Thiele H et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the crisp ami randomized trial. JAMA 306(12), 1329–1337 (2011). • Randomized-controlled study with over 300 patients demonstrating the effect of IABP and size of infarction.
  Medline CASGoogle Scholar
• 10 Levine GN, Bates ER, Blankenship JC et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. Catheter. Cardiovasc. Interv. 82(4), E266–E355 (2013).
  MedlineGoogle Scholar
• 11 Windecker S, Kolh P, Alfonso F et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35(37), 2541–2619 (2014).
  MedlineGoogle Scholar
• 12 Ahmad T, Wang T, Hilberman E. Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury CME. JCHF 3(1), 30–39 (2015).
  Google Scholar
• 13 Su D, Yan B, Guo L et al. Intra-aortic balloon pump may grant no benefit to improve the mortality of patients with acute myocardial infarction in short and long term: an updated meta-analysis. Medicine 94(19), e876 (2015).
  MedlineGoogle Scholar
• 14 Ahmad Y, Sen S, Shun-Shin MJ et al. Intra-aortic balloon pump therapy for acute myocardial infarction: a meta-analysis. JAMA Intern. Med. 175(6), 931–939 (2015). •• Large meta-analysis including both randomized-controlled and observational data for IABP in acute myocardial infarction.
  MedlineGoogle Scholar
• 15 Unverzagt S, Buerke M, De Waha A et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst. Rev. (3), CD007398 (2015). • SHOCK-II trial with 600 patients in cardiogenic shock randomized to IABP or no IABP prior to definitive revascularization.
  MedlineGoogle Scholar
• 16 Thiele H, Zeymer U, Neumann F-J et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 367(14), 1287–1296 (2012).
  Medline CASGoogle Scholar
• 17 Prondzinsky R, Lemm H, Swyter M et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit. Care Med. 38(1), 152–160 (2010).
  Medline CASGoogle Scholar
• 18 Arias E, González-Chon O, García-López S et al. Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction. Arch. Cardiol. Mex. 75(3), 260–266 (2005).
  MedlineGoogle Scholar
• 19 Kapur NK, Paruchuri V, Majithia A et al. Hemodynamic effects of standard versus larger-capacity intraaortic balloon counterpulsation pumps. J. Invasive Cardiol. 27(4), 182–188 (2015).
  MedlineGoogle Scholar
• 20 Pilarczyk K, Boening A, Jakob H et al. Preoperative intra-aortic counterpulsation in high-risk patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Eur. J. Cardiothorac. Surg. 49(1), 5–17 (2016). • Comprehensive meta-analysis with data from randomized-controlled studies for IABP prior to cardiac surgery.
  MedlineGoogle Scholar
• 21 Christenson JT, Simonet F, Badel P, Schmuziger M. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann. Thorac. Surg. 68(3), 934–939 (1999).
  Medline CASGoogle Scholar
• 22 Christenson JT, Simonet F, Badel P, Schmuziger M. Evaluation of preoperative intra-aortic balloon pump support in high-risk coronary patients. Eur. J. Cardiothorac. Surg. 11(6), 1097–1103 (1997).
  Medline CASGoogle Scholar
• 23 Christenson JT, Simonet F, Badel P, Schmuziger M. The effect of preoperative intra-aortic balloon pump support in patients with coronary artery disease, poor left-ventricular function (LVEF < 40%), and hypertensive LV hypertrophy. Thorac. Cardiovasc. Surg. 45(02), 60–64 (1997).
  Medline CASGoogle Scholar
• 24 Christenson JT, Badel P, Simonet F, Schmuziger M. Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG. Ann. Thorac. Surg. 64(5), 1237–1244 (1997).
  Medline CASGoogle Scholar
• 25 Wilczyński M, Krzych L, Bis J, Szmagała P, Ulczok R, Bochenek A. Effect of gender on efficacy of preoperative intra-aortic balloon pump in high-risk patients undergoing surgical coronary revascularisation. Kardiol. Pol. 68(12), 1361–1368 (2010).
  MedlineGoogle Scholar
• 26 Christenson JT, Marc L, Afksendiyos K. The role of intra-aortic counterpulsation in high-risk opcab surgery: a prospective randomized study. J. Card. Surg. 18(4), 279–374 (2003).
  MedlineGoogle Scholar
• 27 Shi M, Huang J, Pang L, Wang Y. Preoperative insertion of an intra-aortic balloon pump improved the prognosis of high-risk patients undergoing off-pump coronary artery bypass grafting. J. Int. Med. Res. 39(4), 1163–1168 (2011).
  Medline CASGoogle Scholar
• 28 Christenson JT, Simonet F, Schmuziger M. Economic impact of preoperative intraaortic balloon pump therapy in high-risk coronary patients. Ann. Thorac. Surg. 70(2), 510–515 (2000).
  Medline CASGoogle Scholar
• 29 Metz D, Stiller M, Silber RE, Kroll H, Hofmann HS, Diez C. Prophylaktische intraaortale Ballongegenpulsation bei herzchirurgischen Hochrisikopatienten. Medizinische Klinik – Intensivmedizin und Notfallmedizin 106(2), 125–131 (2011).
  Medline CASGoogle Scholar
• 30 Ranucci M, Castelvecchio S, Biondi A et al. A randomized controlled trial of preoperative intra-aortic balloon pump in coronary patients with poor left ventricular function undergoing coronary artery bypass surgery. Crit. Care Med. 41(11), 2476–2483 (2013). • Randomized-controlled study with IABP and measure of hemodynamic parameters.
  MedlineGoogle Scholar
• 31 Parissis H, Graham V, Lampridis S, Lau M, Hooks G, Mhandu P. IABP: history-evolution-pathophysiology-indications: what we need to know. J. Cardiothorac. Surg. 11, doi:10.1186/s13019-016-0513-0 (2016).
  MedlineGoogle Scholar
• 32 Zangrillo A, Pappalardo F, Dossi R et al. Preoperative intra-aortic balloon pump to reduce mortality in coronary artery bypass graft: a meta-analysis of randomized controlled trials. Crit. Care 19(1), 10 (2015).
  MedlineGoogle Scholar
• 33 Poirier Y, Voisine P, Plourde G et al. Efficacy and safety of preoperative intra-aortic balloon pump use in patients undergoing cardiac surgery: a systematic review and meta-analysis. Int. J. Cardiol. 207, 67–79 (2016). • Comprehensive review of IABP in the context of cardiac surgery. Extensive scope including randomized-controlled and observational studies.
  MedlineGoogle Scholar
• 34 Truby LK, Takeda K, Mauro C et al. Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support. ASAIO J. 63(3), 257–265 (2017).
  MedlineGoogle Scholar
• 35 Makdisi G, Wang IW. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J. Thorac. Dis. 7(7), E166–E176 (2015).
  MedlineGoogle Scholar
• 36 Meani P, Gelsomino S, Natour E et al. Modalities and effects of left ventricle unloading on extracorporeal life support: a review of the current literature. Eur. J. Heart Fail. 19, 84–91 (2017).
  MedlineGoogle Scholar
• 37 Agnihotri AK, Madsen JC, Daggett WM. Surgical treatment of complications of acute myocardial infarction: postinfarction ventricular septal defect and free wall rupture. In: Cardiac Surgery in the Adult. Cohn LH (Ed.). McGraw-Hill Medical New York, NY, USA (2012).
  Google Scholar
• 38 ECLS Registry Report: International Summary. www.elso.org/Registry/Statistics/InternationalSummary.aspx.
  Google Scholar
• 39 Petroni T, Harrois A, Amour J et al. Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Crit. Care Med. 42(9), 2075–2082 (2014).
  Medline CASGoogle Scholar
• 40 Lin L-Y, Liao C-W, Wang C-H et al. Effects of additional intra-aortic balloon counter-pulsation therapy to cardiogenic shock patients supported by extra-corporeal membranous oxygenation. Sci. Rep. 6, 23838 (2016).
  Medline CASGoogle Scholar
• 41 Koudoumas D, Malliaras K, Theodoropoulos S, Kaldara E, Kapelios C, Nanas J. Long-term intra-aortic balloon pump support as bridge to left ventricular assist device implantation. J. Card. Surg. 31(7), 467–471 (2016).
  MedlineGoogle Scholar
• 42 Estep JD, Cordero-Reyes AM, Bhimaraj A et al. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail. 1(5), 382 (2013).
  MedlineGoogle Scholar
• 43 Den Uil CA, Galli G, Jewbali LS et al. First-line support by intra-aortic balloon pump in non-ischaemic cardiogenic shock in the era of modern ventricular assist devices. Cardiology 138(1), 1–8 (2017).
  Medline CASGoogle Scholar
• 44 Cheng JM, Den Uil CA, Hoeks SE et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur. Heart J. 30(17), 2102–2108 (2009).
  MedlineGoogle Scholar
• 45 Amione-Guerra J, Elizondo KJ, Cruz-Solbes AS et al. Cost–effectiveness comparison of intra aortic balloon pump versus left ventricular assist devices as bridge to heart transplant (BTT) strategies. J. Heart Lung Transplant. 35(4), S272–S273 (2016).
  Google Scholar
• 46 Shah A, Retzer E, Nathan S et al. Clinical and economic effectiveness of percutaneous ventricular assist devices for high-risk patients undergoing percutaneous coronary intervention. J. Invasive Cardiol. 27(3), 148–154 (2015).
  MedlineGoogle Scholar
• 47 Schulz A, Krabatsch T, Schmitto JD et al. Preliminary results fromthe C-Pulse OPTIONS HF European multicenter post-market study.. Med. Sci. Monit. Basic Res. 18(22), 14–19 (2016).
  Google Scholar